694
Views
4
CrossRef citations to date
0
Altmetric
Brief Report

Anti-p21 autoantibodies detected in colorectal cancer patients: A proof of concept study

, , , , &
Article: e952202 | Received 10 May 2014, Accepted 04 Jun 2014, Published online: 30 Oct 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Osama Adnan Kensara, Adel Galal El-Shemi, Amr Mohamed Mohamed, Bassem Refaat, Shakir Idris & Jawwad Ahmad. (2016) Thymoquinone subdues tumor growth and potentiates the chemopreventive effect of 5-fluorouracil on the early stages of colorectal carcinogenesis in rats. Drug Design, Development and Therapy 10, pages 2239-2253.
Read now

Articles from other publishers (3)

Mohammad Mirza-Aghazadeh-Attari, Saber Ghazizadeh Darband, Mojtaba Kaviani, Ainaz Mihanfar, Javad Aghazadeh Attari, Bahman Yousefi & Maryam Majidinia. (2018) DNA damage response and repair in colorectal cancer: Defects, regulation and therapeutic implications. DNA Repair 69, pages 34-52.
Crossref
Adel Galal El-Shemi, Bassem Refaat, Osama Adnan Kensara, Amr Mohamed Mohamed, Shakir Idris & Jawwad Ahmad. (2016) Paricalcitol Enhances the Chemopreventive Efficacy of 5-Fluorouracil on an Intermediate-Term Model of Azoxymethane-Induced Colorectal Tumors in Rats. Cancer Prevention Research 9:6, pages 491-501.
Crossref
Lorenzo Galluzzi, José Manuel Bravo-San Pedro, Oliver Kepp & Guido Kroemer. (2016) Regulated cell death and adaptive stress responses. Cellular and Molecular Life Sciences 73:11-12, pages 2405-2410.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.